0001571049-16-020777.txt : 20161221 0001571049-16-020777.hdr.sgml : 20161221 20161221210327 ACCESSION NUMBER: 0001571049-16-020777 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161219 FILED AS OF DATE: 20161221 DATE AS OF CHANGE: 20161221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP CENTRAL INDEX KEY: 0001069899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 131840497 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-329-7300 MAIL ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC DATE OF NAME CHANGE: 19980908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Miller Larry Lee CENTRAL INDEX KEY: 0001603584 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36410 FILM NUMBER: 162064959 MAIL ADDRESS: STREET 1: 8 HAZELWOOD COURT CITY: WARREN STATE: NJ ZIP: 07059 FORMER NAME: FORMER CONFORMED NAME: Miller Larry Lars DATE OF NAME CHANGE: 20140325 4 1 t1603145_x2.xml OWNERSHIP DOCUMENT X0306 4 2016-12-19 0 0001069899 PHIBRO ANIMAL HEALTH CORP PAHC 0001603584 Miller Larry Lee 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666-6712 0 1 0 0 Chief Operating Officer Class A Common Stock 2016-12-19 4 M 0 252 11.83 A 252 D Class A Common Stock 2016-12-19 4 S 0 252 30.00 D 0 D Class A Common Stock 2016-12-20 4 M 0 1540 11.83 A 1540 D Class A Common Stock 2016-12-20 4 S 0 1540 30.04 D 0 D Option to purchase Class A Common Stock 11.83 2016-12-19 4 M 0 252 0 D 2013-04-29 2019-02-28 Class A Common Stock 252 366602 D Option to purchase Class A Common Stock 11.83 2016-12-20 4 M 0 1540 0 D 2013-04-29 2019-02-28 Class A Common Stock 1540 365062 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.10, inclusive. /s/ Thomas G. Dagger, as Attorney-in-Fact for Larry L. Miller 2016-12-21